Product NDC: | 0409-3380 |
Proprietary Name: | Sufentanil Citrate |
Non Proprietary Name: | SUFENTANIL CITRATE |
Active Ingredient(s): | 50 ug/mL & nbsp; SUFENTANIL CITRATE |
Administration Route(s): | EPIDURAL; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-3380 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074534 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111011 |
Package NDC: | 0409-3380-49 |
Package Description: | 10 AMPULE in 1 CONTAINER (0409-3380-49) > 1 mL in 1 AMPULE |
NDC Code | 0409-3380-49 |
Proprietary Name | Sufentanil Citrate |
Package Description | 10 AMPULE in 1 CONTAINER (0409-3380-49) > 1 mL in 1 AMPULE |
Product NDC | 0409-3380 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | SUFENTANIL CITRATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | EPIDURAL; INTRAVENOUS |
Start Marketing Date | 20111011 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | SUFENTANIL CITRATE |
Strength Number | 50 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |